Exploration of in vitro drug release testing methods for saquinavir microenvironmental pH modifying buccal films

Eur J Pharm Sci. 2021 Aug 1:163:105867. doi: 10.1016/j.ejps.2021.105867. Epub 2021 May 2.

Abstract

Buccal films containing a pH modifying excipient may be able to increase bioavailability of drugs with pH-dependent solubility such as saquinavir. Access to suitable in vitro drug release testing methods may facilitate buccal formulation development. This study aimed to explore two release testing methods for characterising buccal films and to elucidate the relationship between microenvironmental pH (pHM, i.e. the pH around the swelling films) and saquinavir release. The Franz diffusion cell method was applicable to investigate the effect of hydroxypropyl methylcellulose (HPMC) grade on saquinavir release. Films containing HPMC K3 LV had a faster saquinavir release than films containing HPMC K100 LV. A UV/Vis imaging method was developed to visualise saquinavir release and pHM changes during the initial dissolution. Within 5 min, the pHM decreased from 6.8 to around 5.4 for HPMC K100 LV-based films containing 11.1 % or 16.6 % (w/w) malic acid. Subsequently, the pHM increased due to increasing concentrations of saquinavir. An increase in malic acid content led to a faster saquinavir release. The combination of methods may be broadly applicable for excipient screening in development of buccal formulations. The imaging approach holds promise for characterizing other pH modifying formulation principles.

Keywords: Drug release testing method; Franz diffusion cell; Microenvironmental pH; Saquinavir buccal film; UV/Vis imaging.

MeSH terms

  • Chemistry, Pharmaceutical*
  • Drug Liberation
  • Hydrogen-Ion Concentration
  • Hypromellose Derivatives
  • Saquinavir*
  • Solubility

Substances

  • Hypromellose Derivatives
  • Saquinavir